Related Experiment Videos

Factors affecting bone mineral density in hemodialysis patients with diabetic nephropathy

Hiroshi Kaji1, Saburo Hattori, Kenichi Sekita

  • 1Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe Graduate University School of Medicine, Kobe 650-0017, Japan.

Endocrine Journal
|June 14, 2003
PubMed

Insights

Bone mineral density (BMD) in hemodialysis (HD) patients with diabetes mellitus (DM) was comparable to those with chronic glomerulonephritis (CGN). Factors influencing BMD, however, differed between the two groups.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Bone mineral density (BMD) in hemodialysis (HD) patients with diabetes mellitus (DM) remains unclear.
  • This study compares BMD between HD patients with DM and chronic glomerulonephritis (CGN).

Purpose of the Study:

  • To compare forearm BMD between HD patients with DM and CGN.
  • To identify factors affecting BMD in these patient groups.

Main Methods:

  • Cross-sectional study of 139 chronic HD patients.
  • Forearm BMD (1/3-radius and ultradistal) measured using dual-energy x-ray absorptiometry.

Main Results:

  • Forearm BMD was comparable between DM and CGN patients.
  • In DM patients, BMI, creatinine, and beta2-microglobulin (betaMG) affected BMD.
  • In CGN patients, HD duration, height, uric acid, triglyceride, and total cholesterol affected BMD.

Conclusions:

  • Forearm BMD is similar in HD patients with DM and CGN.
  • Factors influencing BMD differ significantly between DM and CGN patients on HD.
Abstract

Related Concept Videos